A phase IIII, randomised, observer blind, placebo controlled, multi centre, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals' herpes Zoster gE/AS01

Project: Research

StatusFinished
Effective start/end date1/11/121/03/14